Retraction
Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
Paper Information
Record ID:
53832
Author(s):
Journal:
Publication Date:
April 21, 2017
Retraction Date:
May 14, 2024
(1.5 year years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1038/s41598-024-61893-8Additional Notes:
see also: https://pubpeer.com/publications/F36DB87292F34D535E4BE264779F2E
Citations (59)
59
Total Citations4
Post-Retraction(6.8%)
55
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
434
Days since retraction (latest)
Repurposing of Drugs Targeting YAP-TEAD Functions
Gian Marco Elisi, Matteo Santucci, Domenico D’Arca et al. (10 authors)
Cancers
Open Access
Published: Sep 2018
41 citations
41 citations
2069 days before retraction
The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases
Mubarak A. Alamri, Hachemi Kadri, Luke J. Alderwick et al. (5 authors)
ChemBioChem
Open Access
Published: Jul 2018
27 citations
27 citations
2133 days before retraction
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival
Enrique Rozengurt, James Sinnett‐Smith, Guido Eibl
Signal Transduction and Targeted Therapy
Open Access
Published: Apr 2018
134 citations
134 citations
2217 days before retraction
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Janine Warren, Yuxuan Xiao, John M. Lamar
Cancers
Open Access
Published: Apr 2018
154 citations
154 citations
2226 days before retraction
Active epithelial Hippo signaling in idiopathic pulmonary fibrosis
Jason J. Gokey, Anusha Sridharan, Yan Xu et al. (8 authors)
JCI Insight
Open Access
Published: Mar 2018
130 citations
130 citations
2246 days before retraction
Receptor Tyrosine Kinase AXL is a Potential Therapeutic Target in Muscle-Invasive Bladder Cancer
Hanaa Al-Mahmoodi
Unknown Journal
Published: Mar 2018
2254 days before retraction
The Hippo pathway as a drug target in gastric cancer
Yiting Qiao, Tongyu Li, Shusen Zheng et al. (4 authors)
Cancer Letters
Published: Jan 2018
65 citations
65 citations
2295 days before retraction
Verteporfin inhibits growth of human glioma in vitro without light activation
Ahmad Al‐Moujahed, Katarzyna Brodowska, Tomasz P. Stryjewski et al. (9 authors)
Scientific Reports
Open Access
Published: Aug 2017
82 citations
82 citations
2477 days before retraction
Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation
Min Chen, Liang Zhong, Shifei Yao et al. (11 authors)
International Journal of Medical Sciences
Open Access
Published: Jan 2017
20 citations
20 citations
2690 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #54187
Mar 13, 2024Quick Stats
Total Citations:
59
Years Since Retraction:
1.5 year
Open Access:
Yes
Last Checked:
Jul 24, 2025